Authors
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Listening to the heart: Lessons from cardiology in remote monitoring and AIRather than speculating in a vacuum about the future of remote monitoring in ophthalmology, it is better to explore how other specialties in medicine adopted and integrated remote monitoring into their care plan frameworks.
Latest:
Reducing site burden and expanding research capacity with AIHow artificial intelligence could enhance clinical trials.
Latest:
Dexamethasone rebuttal: Who should perform intravitreal injections?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
New retinotomy technique reduces retinal surgery complications, improves recoveryOphthalmologist Tarek Hassan introduces new surgical approach for proliferative vitreoretinopathy, using precise small retinotomies instead of extensive retinal removal to improve patient outcomes.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Significance of periphery in diabetic retinopathy diagnosis and managementBeing able to visualize and evaluate the retinal periphery provides a better understanding of the disease status and supports a better treatment decision.
Latest:
RHONE-X trial evaluates extended dosing in DME patientsFour-year study shows faricimab in treat-and-extend regimen maintains vision for diabetic macular edema patients with significantly fewer injections over time.
Latest:
2023: What awaits ophthalmology in the year aheadAs we approach the end of 2022, members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
Latest:
Ruth Hogg, PhD, on what retinal imaging can tell clinicians about the brain and bodyWith detailed imaging and cognitive data, the Northern Ireland Cohort for the Longitudinal Study of Aging highlights the potential of integrating eye scans into broader health research.
Latest:
Big data: Driving opportunity for real-world evidenceEvidence-based medicine can lead to personalized care, better results for patients
Latest:
Enhanced OCT GA segmentation achieved with new multistage modelResearchers introduce a multistage dual-branch network to improve accuracy and efficiency.
Latest:
Practice perspective: Academic retinaA window into the world of academic retina practice today.
Latest:
OCT: First 2D image by Adolf Fercher paved the way for today’s imaging techniqueIn the 30 years since optical coherence tomography was first described, it has become one of the most widely used technologies for imaging the human eye.
Latest:
Discussing worldwide pathological myopiaDr. Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Latest:
Advancing ocular pharmacotherapy through the suprachoroidal spaceInsights on injection technique and the future potential of SCS treatments.
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
The future of retina: New targets and more durable solutionsAmong the promising areas of retinal disease research are innovative approaches targeting pan-vascular endothelial growth factor inhibition.
Latest:
David Tanzer, MD, CMO of Lexitas reflects on Retina World CongressLexitas Pharma Services' CMO discusses groundbreaking ophthalmology conference, emphasizing innovative clinical trials, emerging treatments for eye diseases, and the potential for transformative patient care strategies.
Latest:
Expanding our vision of steroid-eluting implantsHow long-term intravitreal steroid technology fits into a modern clinic.
Latest:
Optogenetics for retinal diseaseA mutation-agnostic gene therapy approach offers new possibilities for patients with advanced retinal disease.
Latest:
Adapting medical retina service in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key
Latest:
Perspectives on intravenous bevacizumab repackaged for intravitreal useAlthough off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.
Latest:
Impact of Durable Therapies on Patients and Clinics and Monitoring StrategiesPanelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.
Latest:
EyeCare Partners releases Quality and Outcomes Report, highlights optometric successesThe report highlights clinical successes, innovation, research, and patient outcomes.
Latest:
Listening to the heart: Lessons from cardiology in remote monitoring and AIRather than speculating in a vacuum about the future of remote monitoring in ophthalmology, it is better to explore how other specialties in medicine adopted and integrated remote monitoring into their care plan frameworks.
Latest:
Impressions and take away points from Patient Case #2A retina specialist discusses impressions and key take away points from patient case.
